With Duchenne Filing Due, Santhera Moves Vamorolone Into Becker Muscular Dystrophy

Rare Disease Trial Receiving FDA Funding

 
• By Andrew McConaghie
  
Muscular dystrophy wheelchair user
Becker muscular dystrophy is more rare and slower in onset than Duchenne, but still leaves individuals unable to walk. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D